Islet Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-25,000	Closed	-$1.84M	–	104
2020 Q2	$1.84M	Buy	+25,000	New	+$1.84M	0.21%	62